Vaccination of immunocompromised children — branching viva

Opening framework

My framework has four questions, applied in order. First, what is the immune defect — could this be a combined T-cell defect, which is the one state that turns a safe live vaccine into fatal disease? Second, is the vaccine in question live-attenuated or inactivated, because that single sorting decides the safety question. Third, what is the timing relative to the immunosuppression — corticosteroid dose and duration, chemotherapy cycle, time since transplant. Fourth, how will I verify that the vaccine worked, because in this population a complete record does not equal immunity. [1]

The threat gate

Before any vaccine today I run the threat gate. This infant could have severe combined immunodeficiency: there is no newborn SCID screen on file, a family history of early male infant death, persistent oral thrush, and faltering growth. A live-attenuated vaccine is irreversible once injected, and in a combined defect it can cause disseminated BCG, vaccine-strain rotavirus enteritis, or vaccine-strain varicella. So the single most important safety decision is to withhold all live vaccines until a combined T-cell defect is excluded. The vaccines at risk are BCG, rotavirus, MMR, and varicella. [1] [5] [7]

Confirming or excluding the defect

I confirm or exclude the defect with the TREC newborn screen and, where abnormal or unavailable, flow cytometry for lymphocyte subsets — T, B, and NK cells — with functional T-cell testing. I also send a baseline immunoglobulin level and full blood count. The pattern of lymphocyte subsets localises the block and predicts both the inheritance and the live-vaccine risk. Until those results are available, the live vaccines remain held. [5]

Inactivated vaccines and the household

Inactivated vaccines — DTPa, IPV, Hib, hepatitis B, pneumococcal, inactivated influenza, meningococcal — cannot replicate and are safe to give on schedule, because the harm in this population is not from inactivated vaccines but from leaving the child unprotected while a combined defect is being characterised. I would also address the household: fully vaccinate siblings and carers (cocooning) with inactivated influenza, COVID-19, MMR, and varicella, and explicitly ensure household contacts do not receive oral polio or live rotavirus, which shed live virus toward the infant. [2] [1]

Branch: the corticosteroid threshold

If the examiner branches to a child on systemic corticosteroids, I apply the ACIP threshold verbatim: live vaccines are contraindicated at prednisolone 2 mg/kg/day or more, or 20 mg/day or more for a child over 10 kg, for 14 days or longer, and are withheld for at least four weeks after stopping. Short courses, alternate-day dosing, and inhaled or topical steroids do not meet the threshold and do not restrict live vaccines. The principle is that iatrogenic risk tracks the dose and duration of current therapy, not a permanent label. [2]

Branch: post-haematopoietic stem cell transplant

For the seven-year-old two years post-transplant, I would not rely on her pre-transplant record. Conditioning erases prior immunity, so the schedule must be rebuilt on evidence of reconstitution. I re-vaccinate with inactivated vaccines first — DTPa, IPV, Hib, hepatitis B, pneumococcal, inactivated influenza, meningococcal — from around three to six months post-transplant once reconstitution is documented, and I re-introduce live vaccines, MMR and varicella, only after T-cell recovery is confirmed, typically around two years in the stable, graft-versus-host-disease-free child. I then check post-vaccine serology for tetanus, pneumococcal, Hib, and hepatitis B, and re-vaccinate non-responders rather than assuming the record is correct. [1] [8]

Closing: coordination and the trap to avoid

The closing point is coordination and the classic trap. The trap is to treat immunocompromised as a single state and to delay everything under the illusion of safety — which leaves the child exposed to influenza, pneumococcus, and pertussis. The correct reflex is to give inactivated vaccines promptly and optimally, and to withhold only the live vaccines until the defect and the timing permit. The plan is shared: the specialist service owns the defect-specific rules, the general practitioner owns the routine and catch-up schedule, and a written, reconciled record travels with the child at every transition. [1] [8]